This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert J. Kaplan, MD; Lauren Daman, MD; E. William Rosenberg, MD; Seth Feigenbaum, MA
Memphis, Tenn

Arch Dermatol. 1977;113(1):107.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

In the June ARCHIVES (112:880-881, 1976) we reported the results of a paired comparison, double-blind study, which showed a cream containing caffeine in hydrophilic base was superior to a hydrophilicbase placebo in producing a subjective feeling of improvement in patients with atopic dermatitis. In an effort to pursue this further, we designed another study, this time using a 30% caffeine cream.

The first 40 consecutively seen patients from our dermatology outpatient clinic with typical manifestations of atopic dermatitides who agreed to participate in the study were randomly assigned to either the caffeine or placebo group. Each patient received only one product, either the caffeine cream or the placebo. The identities of the coded creams were unknown to both the patient and the physician. Patients were observed weekly over a three-week period. Each patient was checked for pruritus, erythema, scaling, lichenification, oozing, and excoriation. Twenty-eight patients satisfactorily completed . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?